Literature DB >> 18386188

Gene expression profiles of mouse striatum in control and maneb + paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts.

Suman Patel1, Kavita Singh, Seema Singh, Mahendra Pratap Singh.   

Abstract

The present study was undertaken to investigate the gene expression patterns of the striatum of control and maneb + paraquat-induced Parkinson's disease (PD) phenotype in mouse to identify the differentially expressed transcripts. The animals were treated with and without maneb (30 mg/kg, i.p.) + paraquat (10 mg/kg, i.p.), twice a week, for 3, 6, and 9 weeks. The RNA was isolated from control and treated mouse striatum and reverse transcribed, and equal quantities of labeled cDNA were mixed and hybridized with mouse 15 k arrays. Comparative transcription patterns showed the time of exposure dependent alteration in the expression of several transcripts associated with various pathways. RT-PCR reconfirmed the differential expression of some energy metabolizing transcripts. The study provides maneb + paraquat-induced differential expression of many transcripts using high-density microarray approach. Few transcripts, which were previously not reported to be associated with neuronal degeneration, were also identified. The results obtained thus suggest that maneb + paraquat induce neurotoxicity in the striatum in a time of exposure dependent manner via multiple pathways and defective energy metabolism could play a critical role.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18386188     DOI: 10.1007/s12033-008-9060-9

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  36 in total

Review 1.  Huntington's disease: progress and potential in the field.

Authors:  Edward C Stack; Robert J Ferrante
Journal:  Expert Opin Investig Drugs       Date:  2007-12       Impact factor: 6.206

2.  Regulation of dopamine D(1) receptor trafficking by protein kinase A-dependent phosphorylation.

Authors:  John N Mason; Laura B Kozell; Kim A Neve
Journal:  Mol Pharmacol       Date:  2002-04       Impact factor: 4.436

Review 3.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

Review 4.  Parkinson's disease: from brain homogenate to treatment.

Authors:  O Hornykiewicz
Journal:  Fed Proc       Date:  1973-02

5.  Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype.

Authors:  Mona Thiruchelvam; Eric K Richfield; Becky M Goodman; Raymond B Baggs; Deborah A Cory-Slechta
Journal:  Neurotoxicology       Date:  2002-10       Impact factor: 4.294

6.  Estrogen-related receptor alpha is a repressor of phosphoenolpyruvate carboxykinase gene transcription.

Authors:  Birger Herzog; Jessica Cardenas; Robert K Hall; Josep A Villena; Philip J Budge; Vincent Giguère; Daryl K Granner; Anastasia Kralli
Journal:  J Biol Chem       Date:  2005-11-02       Impact factor: 5.157

7.  Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.

Authors:  Mona Thiruchelvam; Alison McCormack; Eric K Richfield; Raymond B Baggs; A William Tank; Donato A Di Monte; Deborah A Cory-Slechta
Journal:  Eur J Neurosci       Date:  2003-08       Impact factor: 3.386

8.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

9.  Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes.

Authors:  Xia Shen; Shirong Zheng; Visith Thongboonkerd; Ming Xu; William M Pierce; Jon B Klein; Paul N Epstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-07-27       Impact factor: 4.310

10.  Developmental pesticide models of the Parkinson disease phenotype.

Authors:  Deborah A Cory-Slechta; Mona Thiruchelvam; Brian K Barlow; Eric K Richfield
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

View more
  14 in total

1.  Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation?

Authors:  Satya Prakash Gupta; Suman Patel; Sharawan Yadav; Anand Kumar Singh; Seema Singh; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2010-05-09       Impact factor: 3.996

Review 2.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

3.  Cypermethrin-induced nigrostriatal dopaminergic neurodegeneration alters the mitochondrial function: a proteomics study.

Authors:  Sonal Agrawal; Ashish Singh; Pratibha Tripathi; Manisha Mishra; Pradhyumna Kumar Singh; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2014-04-24       Impact factor: 5.590

4.  Activity-based protein profiling of organophosphorus and thiocarbamate pesticides reveals multiple serine hydrolase targets in mouse brain.

Authors:  Daniel K Nomura; John E Casida
Journal:  J Agric Food Chem       Date:  2010-07-21       Impact factor: 5.279

5.  Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson's disease phenotype in the mouse.

Authors:  Sharawan Yadav; Satya Prakash Gupta; Garima Srivastava; Pramod Kumar Srivastava; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2011-12-27       Impact factor: 3.996

Review 6.  Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?

Authors:  Naveen Kumar Singhal; Garima Srivastava; Sonal Agrawal; Swatantra Kumar Jain; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2011-12-24       Impact factor: 5.590

7.  Cypermethrin alters the expression profile of mRNAs in the adult rat striatum: a putative mechanism of postnatal pre-exposure followed by adulthood re-exposure-enhanced neurodegeneration.

Authors:  Manindra Nath Tiwari; Anand Kumar Singh; Sonal Agrawal; Satya Prakash Gupta; Anurag Jyoti; Rishi Shanker; Om Prakash; Mahendra Pratap Singh
Journal:  Neurotox Res       Date:  2012-04-21       Impact factor: 3.911

Review 8.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

9.  Silymarin- and melatonin-mediated changes in the expression of selected genes in pesticides-induced Parkinsonism.

Authors:  Naveen Kumar Singhal; Amit Kumar Chauhan; Swatantra Kumar Jain; Rishi Shanker; Chetna Singh; Mahendra Pratap Singh
Journal:  Mol Cell Biochem       Date:  2013-08-22       Impact factor: 3.396

10.  Acute Maneb Exposure Significantly Alters Both Glycolysis and Mitochondrial Function in Neuroblastoma Cells.

Authors:  Colin C Anderson; Stefanos Aivazidis; Crystal L Kuzyk; Abhilasha Jain; James R Roede
Journal:  Toxicol Sci       Date:  2018-09-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.